Literature DB >> 17125247

Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors.

Kazutaka Ikegashira1, Takahiro Oka, Shintaro Hirashima, Satoru Noji, Hiroshi Yamanaka, Yoshinori Hara, Tsuyoshi Adachi, Jun-Ichiro Tsuruha, Satoki Doi, Yasunori Hase, Toru Noguchi, Izuru Ando, Naoki Ogura, Satoru Ikeda, Hiromasa Hashimoto.   

Abstract

We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical and cellular potencies. These compounds displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125247     DOI: 10.1021/jm0610245

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Development of CINPA1 analogs as novel and potent inverse agonists of constitutive androstane receptor.

Authors:  Wenwei Lin; Lei Yang; Sergio C Chai; Yan Lu; Taosheng Chen
Journal:  Eur J Med Chem       Date:  2015-12-15       Impact factor: 6.514

2.  Preclinical characterization of JTK-853, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Izuru Ando; Tsuyoshi Adachi; Naoki Ogura; Yukiyo Toyonaga; Kazuyuki Sugimoto; Hiroyuki Abe; Masafumi Kamada; Toru Noguchi
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

3.  Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Romain Haudecoeur; Abdelhakim Ahmed-Belkacem; Wei Yi; Antoine Fortuné; Rozenn Brillet; Catherine Belle; Edwige Nicolle; Coralie Pallier; Jean-Michel Pawlotsky; Ahcène Boumendjel
Journal:  J Med Chem       Date:  2011-07-06       Impact factor: 7.446

4.  Single-flask synthesis of N-acylated indoles by catalytic dehydrogenative coupling with primary alcohols.

Authors:  Brooks E Maki; Karl A Scheidt
Journal:  Org Lett       Date:  2009-04-02       Impact factor: 6.005

5.  QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine.

Authors:  Eslam Pourbasheer; Siavash Riahi; Mohammad Reza Ganjali; Parviz Norouzi
Journal:  Mol Divers       Date:  2010-10-08       Impact factor: 2.943

6.  Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.

Authors:  Tanaji T Talele; Payal Arora; Shridhar S Kulkarni; Maulik R Patel; Satyakam Singh; Maksim Chudayeu; Neerja Kaushik-Basu
Journal:  Bioorg Med Chem       Date:  2010-05-15       Impact factor: 3.641

7.  Thumb inhibitor binding eliminates functionally important dynamics in the hepatitis C virus RNA polymerase.

Authors:  Brittny C Davis; Ian F Thorpe
Journal:  Proteins       Date:  2012-09-15

8.  1a/1b subtype profiling of nonnucleoside polymerase inhibitors of hepatitis C virus.

Authors:  Origène Nyanguile; Benoit Devogelaere; Leen Vijgen; Walter Van den Broeck; Frederik Pauwels; Maxwell D Cummings; Hendrik L De Bondt; Ann M Vos; Jan M Berke; Oliver Lenz; Geneviève Vandercruyssen; Katrien Vermeiren; Wendy Mostmans; Pascale Dehertogh; Frédéric Delouvroy; Sandrine Vendeville; Koen VanDyck; Koen Dockx; Erna Cleiren; Pierre Raboisson; Kenneth A Simmen; Gregory C Fanning
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

9.  Genotypic and phenotypic analyses of hepatitis C virus from patients treated with JTK-853 in a three-day monotherapy.

Authors:  Naoki Ogura; Yukiyo Toyonaga; Izuru Ando; Kunihiro Hirahara; Tsutomu Shibata; Gabriela Turcanu; Sudhakar Pai; Kan Yee; Barbara Gerhardt; Maribel Rodriguez-Torres; Toru Noguchi
Journal:  Antimicrob Agents Chemother       Date:  2012-11-05       Impact factor: 5.191

10.  Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors.

Authors:  Neerja Kaushik-Basu; Alain Bopda-Waffo; Tanaji T Talele; Amartya Basu; Paulo R R Costa; Alcides J M da Silva; Stefan G Sarafianos; François Noël
Journal:  Nucleic Acids Res       Date:  2008-01-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.